A randomised trial to compare post-operative respiratory function following bolus abdominal block local anaesthesia, versus standard infusional abdominal block local anaesthesia in patients undergoing gastrointestinal resectional surgery
A Randomised Trial to compare post-operative respiratory function in patients receiving bolus abdominal block local anaesthesia, to patients receiving the standard infusional abdominal block local anaesthesia in patients undergoing gastrointestinal resectional surgery
Hunter New England Local Health District
120 participants
Apr 9, 2013
Interventional
Conditions
Summary
The study is trying to find out which is the best way to deliver a medication for pain relief called a local anaesthetic (a drug that helps to numb areas of the body e.g. the skin) to the abdominal wall in patients undergoing major abdominal surgery in order to help reduce the post-operative pain.
Eligibility
Inclusion Criteria8
- All patients undergoing elective or semi-urgent booked abdominal gastrointestinal resectional surgery at the following institutions:
- John Hunter Hospital
- Newcastle Private Hospital
- Belmont District Hospital
- The Calvary Mater Newcastle
- Lake Macquarie Private Hospital
- The Maitland Hospital
- Maitland Private Hospital
Exclusion Criteria9
- Refusal or unable to give written, informed consent to participate in the study, or
- Patient has received an epidural, spinal or other neuroaxial anaesthetic
- Patient is under 18 years of age, or
- Patient receives an operation that involves extra incisions outside the abdominal wall (such as abdomino-perineal resections), or
- Patient has a known allergy or adverse drug reaction to local anaesthetic agents or morphine or fentanyl, or
- Patient has a history of arrhythmia or long QT syndrome associated with the drugs used in this trial, or
- Patient remains intubated post procedure
- Patient is taking regular opiate narcotics pre-operatively
- Patients will be withdrawn from the trial if: - At any time they wish to discontinue with the trial, or Post-operative complications within the first 72 hours result in the patient being unable to be assessed for study outcomes (e.g. requiring post-operative ventilation)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Arm B is intervention: abdominal wall block by bolus administration of the local anaesthetic agent ropivacaine 0.2% every 6 hours until block is removed. Boluses are 20mls of 0.2% ropivacaine through each catheter for bilateral catheters, and 40mls of 0.2% ropivacaine for unilateral catheters. A maximum dose of 0.2% ropivacaine for intervention arm is 3mg/kg for each bolus dose.
Locations(7)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12613000380796